Skip to main content

Month: September 2024

Cibus, Inc. Announces Proposed Public Offering of Class A Common Stock

SAN DIEGO, Sept. 17, 2024 (GLOBE NEWSWIRE) — Cibus, Inc. (Nasdaq: CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that it intends to offer shares of its Class A common stock in an underwritten public offering. Cibus also expects to grant to the underwriters of the offering a 45-day option to purchase up to an additional 15% of the shares of Class A common stock offered in the underwritten public offering on the same terms and conditions. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Certain existing institutional and accredited investors and Rory Riggs,...

Continue reading

Resolute Holdings Completes Acquisition of Majority Interest in CompoSecure

CompoSecure announces board changes with David Cote, former CEO of Honeywell, as executive chairman as well as the appointment of five new board members NEW YORK and SOMERSET, N.J., Sept. 17, 2024 (GLOBE NEWSWIRE) — Resolute Holdings I, LP and its affiliated vehicles (“Resolute”), an investment firm under the leadership of David Cote and Tom Knott, and CompoSecure, Inc. (Nasdaq: CMPO) (“CompoSecure”) today announced the closing of Resolute’s acquisition of a majority interest in CompoSecure in accordance with the stock purchase agreements among Resolute and certain shareholders of CompoSecure. In conjunction with the closing, David Cote has been appointed executive chairman of the board of directors of CompoSecure and Tom Knott, Joseph DeAngelo, Roger Fradin, Mark James, and John Cote have also been appointed to the board of directors. Pursuant...

Continue reading

DarkPulse, Inc. Completes Acquisition of Certain Assets of Optilan UK Ltd Including India and Turkey Subsidiaries

DarkPulse secures global operations and engineering capabilities in India and Turkey as part its Global Strategy HOUSTON, Sept. 17, 2024 (GLOBE NEWSWIRE) — DarkPulse, Inc. (OTC: DPLS) (“DarkPulse”, “DPLS”, or “the Company”) today announced the closing of the acquisition of certain assets of Optilan UK Ltd including two operating subsidiaries. The subsidiaries acquired are Optilan India Pvt Ltd, a major engineering group that designed multiple installations across the globe including security, rail, oil and gas, telecoms and, most importantly, distributed fiber optic sensor systems (DFOSS). The second entity acquired is Optilan Communications & Security Systems Ltd (Turkey) who has played a key role in projects including the Trans-Anatolian Natural Gas Pipeline (TANAP) installation as well as maintenance services...

Continue reading

Aramis Group – Declaration of transactions on own shares conducted from September 9 to 13, 2024

PRESS RELEASE Arcueil, September 17, 2024 Declaration of transactions on own shares conducted from September 9 to 13, 2024 Within the framework of the authorizations granted by the General Assembly on February 9, 2024, to operate on its shares and in accordance with the regulations related to share buybacks, Aramis Group hereby declares the following purchases of own shares (FR0014003U94) made from September 9 to 13, 2024 (excluding the liquidity contract):Nom de l’émetteur Code Identifiant de l’émetteur Jour de la transaction Code identifiant de l’instrument financier Volume total journalier (en nombre d’actions) Prix pondéré moyen journalier d’acquisition des actions MarchéAramis Group 9695002Q984W0T41WB42 2024-09-12 FR0014003U94 851 5,2959 XPARAramis Group ...

Continue reading

NaturalShrimp, Inc. Continues Production Despite Setbacks

DALLAS, TX, Sept. 17, 2024 (GLOBE NEWSWIRE) — NaturalShrimp, Inc. (OTCQB: SHMP) (the “Company” or “NSI”), a Biotechnology Aquaculture Company that has developed and patented the first seafood-focused commercially operational RAS (Recirculating Aquaculture System), today announced that, despite recent litigation, it has entered into discussions with Streeterville Capital, LLC (“Streeterville”) to resolve current issues, including the litigation, and to continue growing and expanding the production of the Company’s sushi grade shrimp. Notwithstanding the litigation in Utah, the principals of both the Company and Streeterville seek a resolution that works for both companies. In this respect, prior to the filing of the lawsuit, representatives of Streeterville toured the Company’s Webster City Facilities in Iowa and were impressed...

Continue reading

Reykjavík Energy | Green Bond Auction September 25th

Reykjavík Energy (Orkuveita Reykjavíkur; Orkuveitan) is holding a bond auction on Wednesday, September 25th, 2024. Bonds in the green bond classes OR280845 GB and OR180255 GB as well as a new green bond class OR031033 GB will be offered for sale. OR031033 GB bears 8.30% fixed nominal interest and pays equal principal payments every six months with a final maturity date of October 3rd, 2033. OR0280845 GB bears fixed indexed interest and pays equal payments every six months with a final maturity date of August 28th, 2045. The bond carries 3.70% fixed interest and is redeemable after 13 years. Previously, bonds with a nominal value of ISK 2,050 million have been issued in the class. OR0180255 GB bears fixed indexed interest and pays equal payments every six months with a final maturity date of February 18th, 2055. Previously, bonds with a...

Continue reading

REPEAT: WESTERN PACIFIC TRUST COMPANY (TSXV: WP) Announces Declaration of Dividend on Common Shares

VANCOUVER, British Columbia, Sept. 17, 2024 (GLOBE NEWSWIRE) — Western Pacific Trust Company (“WPTC”) (TSXV: WP) is pleased to announce that its board of directors has declared its second annual dividend on common shares. This step reflects WPTC’s ongoing growth and underscores the company’s commitment to enhancing shareholder value. The decision to declare this second consecutive annual dividend follows WPTC’s robust financial performance and the company’s optimistic outlook for the future. WPTC has consistently demonstrated strong growth over recent years, supported by its focus on providing competitive, responsive, and expert service in a niche market. “We are delighted to declare our second annual dividend on common shares, which underscores Western Pacific Trust Company’s progress and success,” stated Alison...

Continue reading

Middlesex Water Company CEO Nadine Leslie and CFO Rally Zerhouni to Participate in Janney Virtual Water Utilities Conference

ISELIN, N.J., Sept. 17, 2024 (GLOBE NEWSWIRE) — Middlesex Water Company (the “Company” or “Middlesex Water”) has announced that its President and Chief Executive Officer, Nadine Leslie, and Senior Vice President, Chief Financial Officer and Treasurer, Mohammed G. (Rally) Zerhouni, will be participating in the 4th Annual Virtual Water Utilities Conference hosted by Janney Montgomery Scott on Thursday, September 19, 2024 at 1:00 p.m. (ET). Ms. Leslie and Mr. Zerhouni will be providing a Company update. The Conference is a virtual event to be moderated by Michael Gaugler, Janney Senior Analyst and Managing Director, Utility & Infrastructure. The live presentation as well as a replay of the webcast will be available in real time and be posted at https://wsw.com/webcast/jms13/msex/1693846 or on Middlesex Water’s website www.middlesexwater.com...

Continue reading

Move Health Holdings Corp. and No Fear Counselling Corp. Complete Merger Transaction 

VANCOUVER, British Columbia and TORONTO, Sept. 17, 2024 (GLOBE NEWSWIRE) — Move Health Holdings Corp. (“Move Health”) and No Fear Counselling Corp. (“No Fear Counselling”), two of Canada’s foremost health and wellness organizations, are pleased to announce the successful completion of their highly anticipated all-share merger (the “Transaction”), following unanimous approval at a Special Shareholders Meeting September 13, 2024. Initially announced in a joint press release dated June 27, 2024, the newly combined entity now operates across 70+ locations with a team of over 300+ dedicated physicians, nurse practitioners, and licensed therapists. The organization is responsible for: • Annual Revenue: ~$10M• Gross Margins: 38%• 24/7 Primary Care through Lyte Medical telemedicine platform• Allied health clinics offering physiotherapy,...

Continue reading

FDA approves Novartis Kisqali® to reduce risk of recurrence in people with HR+/HER2- early breast cancer

Ad hoc announcement pursuant to Art. 53 LRBroad indication in HR+/HER2- stage II and III early breast cancer (EBC) at high risk of recurrence approximately doubles population eligible for CDK4/6 inhibitor adjuvant therapy1,2Kisqali® (ribociclib) significantly reduced the risk of recurrence by 25% vs. endocrine therapy (ET) alone; consistent benefit and a well-tolerated safety profile seen across all subgroups in pivotal Phase III NATALEE trial, including patients with node-negative disease3-6Late-breaking NATALEE data recently presented at ESMO provides additional confidence, with deepening of invasive disease-free survival benefit after completion of the three-year treatment period across all patient subgroups7People with stage II or III HR+/HER2- EBC face significant risk of recurrence – often as incurable metastatic disease...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.